Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Schechter, Tal  [Clear All Filters]
2024
Spyrou N, Akahoshi Y, Kowalyk S, Morales G, Beheshti R, Aguayo-Hiraldo P, Malki MMAl, Ayuk F, Bader P, Baez J, et al. A day 14 endpoint for acute GVHD clinical trials. Transplant Cell Ther. 2024.
Chopra Y, Acevedo K, Muise A, Frost K, Schechter T, Krueger J, Ali M, Chiang K-Y, Kim VY, Grunebaum E, et al. Gut immunomodulation with vedolizumab prior to allogeneic hematopoietic stem cell transplantation in pediatric patients with inflammatory bowel disease. Transplant Cell Ther. 2024.
Qayed M, Kapoor U, Gillespie S, Westbrook A, Aguayo-Hiraldo P, A Ayuk F, Aziz M, Baez J, Choe H, DeFilipp Z, et al. A validated risk stratification that incorporates MAGIC biomarkers predicts long term outcomes in pediatric patients with acute GVHD. Transplant Cell Ther. 2024.
2023
Bourkas AN, Sibbald C, Chan A-W, Schechter T, Ali M, Pullattayil AKareem, Levy R. Characterizing the cutaneous late effects of allogeneic hematopoietic stem cell transplantation: A systematic review. Pediatr Transplant. 2023:e14618.
Chopra Y, Hong C, Schechter T, Ali M, Chiang K-Y, Wall D, Krueger J. Intractable abdominal pain as the sole symptom of Varicella Zoster reactivation after allogeneic stem cell transplantation: brief case report and review of the literature. Pediatr Hematol Oncol. 2023:1-5.
Chopra Y, Alsabahi A, Schechter T, Mtaweh H, Sweezey N, Balit C, Ali M, Chiang K-Y, Gassas A, Krueger J. Pulmonary Hemorrhage in Pediatric Hematopoietic Stem Cell Transplant Recipients: A Single-Center Retrospective Study. Pediatr Crit Care Med. 2023.
2021
Jacobs S, Plenert E, Stein E, Mowbray C, Stewart R, Schechter T, Diorio C, Sung L. Challenges of Implementing Multicenter Studies of Yoga for Pediatric Cancer and Hematopoietic Stem Cell Transplantation Recipients. Int J Yoga Therap. 2021.
Zewde MGetachew, Morales G, Gandhi I, Özbek U, Aguayo-Hiraldo P, Ayuk F, Baez J, Chanswangphuwana C, Choe H, DeFilipp Z, et al. Evaluation of elafin as a prognostic biomarker in acute graft-versus-host disease. Transplant Cell Ther. 2021.
Subburaj D, Ng B, Kariminia A, Abdossamadi S, Lauener M, Nemecek ER, Rozmus J, Kharbanda S, Kitko CL, Lewis VAnthony, et al. Metabolomic Identification of Alpha-Ketoglutaric Acid Elevation in Pediatric Chronic Graft-versus-Host Disease. Blood. 2021.
2020
Loves R, Plenert E, Tomlinson V, Palmert S, Green G, Schechter T, Tomlinson D, Vettese E, Zupanec S, L Dupuis L, et al. Changes in hunger among pediatric patients with cancer and hematopoietic stem cell transplantation recipients. Support Care Cancer. 2020.
Ali S, Wall DA, Ali M, Chiang K-Y, Naqvi A, Weitzman S, Gassas A, Gibson P, Brager R, Fernandez CV, et al. Effect of different conditioning regimens on survival and engraftment for children with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoeitic stem cell transplantation: A single institution experience. Pediatr Blood Cancer. 2020;67(9):e28477.
2019
Truong TH, Pole JD, Bittencourt H, Schechter T, Cuvelier GDE, Paulson K, Rayar M, Mitchell D, Schultz KR, O'Shea D, et al. Access to Hematopoietic Stem Cell Transplantation among Pediatric Patients with Acute Lymphoblastic Leukemia: A Population-based Analysis. Biol Blood Marrow Transplant. 2019.
Cook S, Vettese E, Tomlinson GA, Soman D, Schechter T, Kuczynski S, Gladstone B, L Dupuis L, Sung L. Feasibility of a randomized controlled trial of symptom screening and feedback to healthcare providers compared with standard of care using the SPARK platform. Support Care Cancer. 2019.
Srinagesh HK, Özbek U, Kapoor U, Ayuk F, Aziz M, Ben-David K, Choe HK, DeFilipp Z, Etra A, Grupp SA, et al. The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease. Blood Adv. 2019;3(23):4034-4042.
Lazor T, Pole JD, De Souza C, Schechter T, Grant R, Davis H, Duong N, Stein E, Cook S, Tigelaar L, et al. Severity, change over time and risk factors of anxiety in children with cancer depends on anxiety instrument used. Psychooncology. 2019.
2018
Papaz T, Allen U, Blydt-Hansen T, Birk PE, Min S, Hamiwka L, Phan V, Schechter T, Wall DA, Urschel S, et al. Pediatric Outcomes in Transplant: PersOnaliSing Immunosuppression To ImproVe Efficacy (POSITIVE Study): The Collaboration and Design of a National Transplant Precision Medicine Program. Transplant Direct. 2018;4(12):e410.
2016
Gassas A, Krueger J, Schechter T, Zaidman I, Asim M, Ali M. Safety and Role of Gastrointestinal Endoscopy in the Management of Gastrointestinal Acute GVHD in Children After Hematopoietic Stem Cell Transplantation. J Pediatr Hematol Oncol. 2016.
2015
Harris AC, Young R, Devine S, Hogan WJ, Ayuk F, Bunworasate U, Chanswangphuwana C, Efebera YA, Holler E, Litzow M, et al. International, multi-center standardization of acute graft-versus-host disease clinical data collection: a report from the MAGIC consortium. Biol Blood Marrow Transplant. 2015.
Hutspardol S, Essa M, Richardson S, Schechter T, Ali M, Krueger J, Fujii H, R Egeler M, Gassas A. Significant transplant-related mortality from respiratory virus infections within the first 100 days in children post hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2015.
Chellapandian D, Krueger J, Schechter T, Gassas A, Weitzman S, Naqvi A, Ali M. Successful allogeneic hematopoietic stem cell transplantation in XIAP deficiency using reduced-intensity conditioning. Pediatr Blood Cancer. 2015.
Patrick K, Ali M, Richardson SE, Gassas A, Egeler M, Krueger J, Lowry J, Allen U, Schechter T. The yield of monitoring for HSV and VZV viremia in pediatric hematopoietic stem cell transplant patients. Pediatr Transplant. 2015.
2014
Gassas A, Ashraf K, Zaidman I, Ali M, Krueger J, Doyle J, Schechter T, Leucht S. Hematopoietic stem cell transplantation in infants. Pediatr Blood Cancer. 2014.
Schechter T, Naqvi A, Weitzman S. Risk for complications in patients with hemophagocytic lymphohistiocytosis who undergo hematopoietic stem cell transplantation: myeloablative versus reduced-intensity conditioning regimens. Expert Rev Clin Immunol. 2014:1-6.
2013
Ansari M, Uppugunduri CRao S, Ferrari-Lacraz S, Bittencourt H, Gumy-Pause F, Chalandon Y, Tiercy J-M, Schechter T, Gassas A, Doyle JD, et al. The Clinical Relevance of Pre-Formed Anti-HLA and Anti-MICA Antibodies after Cord Blood Transplantation in Children. PLoS One. 2013;8(8):e72141.